{"Ticker": "ABMD", "Company": "Abiomed", "Sector": "Health Care", "Updated": "2022-11-02", "Rating": {"Date": "2022-11-02", "Rating": "Upgrade", "Organization": "Morgan Stanley", "Rating_Change": "Underweight to Equal-Weight", "Target_Change": "$235 to $380"}}
{"Ticker": "ABMD", "Company": "Abiomed", "Sector": "Health Care", "Updated": "2022-11-02", "Rating": {"Date": "2022-11-02", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$355 to $388"}}
{"Ticker": "CTLT", "Company": "Catalent", "Sector": "Health Care", "Updated": "2022-11-02", "Rating": {"Date": "2022-11-02", "Rating": "Downgrade", "Organization": "BofA Securities", "Rating_Change": "Buy to Neutral", "Target_Change": "$125 to $60"}}
{"Ticker": "ECL", "Company": "Ecolab", "Sector": "Materials", "Updated": "2022-11-02", "Rating": {"Date": "2022-11-02", "Rating": "Downgrade", "Organization": "Deutsche Bank", "Rating_Change": "Buy to Hold", "Target_Change": "$165 to $135"}}
{"Ticker": "MSFT", "Company": "Microsoft", "Sector": "Information Technology", "Updated": "2022-11-02", "Rating": {"Date": "2022-11-02", "Rating": "Initiated", "Organization": "Macquarie", "Rating_Change": "Neutral", "Target_Change": "$234"}}
{"Ticker": "NDAQ", "Company": "Nasdaq", "Sector": "Financials", "Updated": "2022-11-02", "Rating": {"Date": "2022-11-02", "Rating": "Downgrade", "Organization": "Credit Suisse", "Rating_Change": "Outperform to Neutral", "Target_Change": "$66 to $57"}}
{"Ticker": "CRM", "Company": "Salesforce", "Sector": "Information Technology", "Updated": "2022-11-02", "Rating": {"Date": "2022-11-02", "Rating": "Resumed", "Organization": "Macquarie", "Rating_Change": "Outperform", "Target_Change": "$210"}}
{"Ticker": "NOW", "Company": "ServiceNow", "Sector": "Information Technology", "Updated": "2022-11-02", "Rating": {"Date": "2022-11-02", "Rating": "Resumed", "Organization": "Macquarie", "Rating_Change": "Outperform", "Target_Change": "$500"}}
